Format

Send to

Choose Destination
Lancet Oncol. 2001 Mar;2(3):141-8.

Mantle-cell lymphoma.

Author information

1
Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

Erratum in

  • Lancet Oncol 2002 Jul;3(7):396.
  • Lancet Oncol 2001 Apr;2(4):198.

Abstract

During the past decade, mantle-cell lymphoma has been established as a new disease entity. The normal counterparts of the cells forming this malignant lymphoma are found in the mantle zone of the lymph node, a thin layer surrounding the germinal follicles. These cells have small to medium-sized nuclei, are commonly indented or cleaved, and stain positively with CD5, CD20, cyclin D1, and FMC7 antibodies. Because of its morphological appearance and a resemblance to other low-grade lymphomas, many of which grow slowly, this lymphoma was initially thought to be an indolent tumour, but its natural course was not thoroughly investigated until the 1990s, when the BCL1 oncogene was identified as a marker for this disease. Mantle-cell lymphoma is a discrete entity, unrelated to small lymphocytic or small-cleaved-cell lymphomas.

Comment in

PMID:
11902564
DOI:
10.1016/S1470-2045(00)00255-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center